Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Epigenetic reprogramming of lymphedema using adipose-derived stem cells

FY 2016-17

Summary
Lymphedema is the obstruction of lymphatic vessels in the human body. It is a common side effect for patients who undergo surgery and/or radiotherapy to treat their cancer. Patients with lymphedema have swelling and loss of function of their affected arm or leg, have increased rates of infection, and report significantly decreased quality of life. Currently, there is no effective treatment for lymphedema. Recent studies have demonstrated that modifications in gene activity levels without direct changes in DNA sequence, called epigenetic changes, may be important in the development of lymphedema. Adipose-derived stem cells (ADSCs) are regenerative cells that are found in fat tissue that can modulate epigenetics. To investigate how ADSCs reverse epigenetic changes in lymphedema, these alterations will be characterized with and without ADSC treatment using high-throughput methods. This data will help identify novel drugs to be used alone or in combination with ADSCs to treat lymphedema. Developing effective treatments for lymphedema will become increasingly important with the rising numbers of cancer survivors. Reversing lymphedema with ADSC-based therapy will improve the health, function, and quality of life of cancer patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367172
Name
Kwan Jennifer Y
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Epigenetic reprogramming of lymphedema using adipose-derived stem cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Epigenetics; Lymphedema; Radiation; Stem Cells; Surgery
Abstract
Lymphedema is the obstruction of lymphatic vessels in the human body. It is a common side effect for patients who undergo surgery and/or radiotherapy to treat their cancer. Patients with lymphedema have swelling and loss of function of their affected arm or leg, have increased rates of infection, and report significantly decreased quality of life. Currently, there is no effective treatment for lymphedema. Recent studies have demonstrated that modifications in gene activity levels without direct changes in DNA sequence, called epigenetic changes, may be important in the development of lymphedema. Adipose-derived stem cells (ADSCs) are regenerative cells that are found in fat tissue that can modulate epigenetics. To investigate how ADSCs reverse epigenetic changes in lymphedema, these alterations will be characterized with and without ADSC treatment using high-throughput methods. This data will help identify novel drugs to be used alone or in combination with ADSCs to treat lymphedema. Developing effective treatments for lymphedema will become increasingly important with the rising numbers of cancer survivors. Reversing lymphedema with ADSC-based therapy will improve the health, function, and quality of life of cancer patients.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kwan, Jennifer Y
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~